JP2008539178A - 5−(4−[4−(5−シアノ−3−インドリル)ブチル]−1−ピペラジニル)ベンゾフラン−2−カルボキサミドの製造方法 - Google Patents
5−(4−[4−(5−シアノ−3−インドリル)ブチル]−1−ピペラジニル)ベンゾフラン−2−カルボキサミドの製造方法 Download PDFInfo
- Publication number
- JP2008539178A JP2008539178A JP2008508108A JP2008508108A JP2008539178A JP 2008539178 A JP2008539178 A JP 2008539178A JP 2008508108 A JP2008508108 A JP 2008508108A JP 2008508108 A JP2008508108 A JP 2008508108A JP 2008539178 A JP2008539178 A JP 2008539178A
- Authority
- JP
- Japan
- Prior art keywords
- carboxamide
- benzofuran
- piperazinyl
- cyano
- indolyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 23
- SGEGOXDYSFKCPT-UHFFFAOYSA-N vilazodone Chemical compound C1=C(C#N)C=C2C(CCCCN3CCN(CC3)C=3C=C4C=C(OC4=CC=3)C(=O)N)=CNC2=C1 SGEGOXDYSFKCPT-UHFFFAOYSA-N 0.000 title claims abstract description 20
- 150000003839 salts Chemical class 0.000 claims abstract description 18
- 239000002253 acid Substances 0.000 claims abstract description 11
- KAMHFQOKYXEWST-UHFFFAOYSA-N 3-(4-oxobutyl)-1h-indole-5-carbonitrile Chemical compound C1=C(C#N)C=C2C(CCCC=O)=CNC2=C1 KAMHFQOKYXEWST-UHFFFAOYSA-N 0.000 claims abstract description 8
- 238000010306 acid treatment Methods 0.000 claims abstract description 7
- 229910052794 bromium Inorganic materials 0.000 claims abstract description 7
- 230000008878 coupling Effects 0.000 claims abstract description 7
- 238000010168 coupling process Methods 0.000 claims abstract description 7
- 238000005859 coupling reaction Methods 0.000 claims abstract description 7
- 238000002360 preparation method Methods 0.000 claims abstract description 7
- 238000006268 reductive amination reaction Methods 0.000 claims abstract description 7
- 229910052723 transition metal Inorganic materials 0.000 claims abstract description 7
- 150000003624 transition metals Chemical class 0.000 claims abstract description 7
- 150000001875 compounds Chemical class 0.000 claims abstract description 6
- YWBYYVAHAWQUDF-UHFFFAOYSA-N 3-(4-piperazin-1-ylbutyl)-1h-indole-5-carbonitrile Chemical compound C12=CC(C#N)=CC=C2NC=C1CCCCN1CCNCC1 YWBYYVAHAWQUDF-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000003054 catalyst Substances 0.000 claims description 5
- CYPYTURSJDMMMP-WVCUSYJESA-N (1e,4e)-1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].[Pd].C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 CYPYTURSJDMMMP-WVCUSYJESA-N 0.000 claims description 3
- QHKJIJXBJCOABP-UHFFFAOYSA-N 1-benzofuran-2-carboxamide Chemical compound C1=CC=C2OC(C(=O)N)=CC2=C1 QHKJIJXBJCOABP-UHFFFAOYSA-N 0.000 abstract description 4
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 abstract description 4
- -1 5-cyano-3-indolyl Chemical group 0.000 abstract description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
- 239000002585 base Substances 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 description 4
- 229960003740 vilazodone Drugs 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- LLRGOAFFRRUFBM-UHFFFAOYSA-N 5-piperazin-1-yl-1-benzofuran-2-carboxamide Chemical compound C=1C=C2OC(C(=O)N)=CC2=CC=1N1CCNCC1 LLRGOAFFRRUFBM-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 150000001299 aldehydes Chemical class 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- BZXNEONCFZGWDS-UHFFFAOYSA-N 3-(4-hydroxybutyl)-1h-indole-5-carbonitrile Chemical compound C1=C(C#N)C=C2C(CCCCO)=CNC2=C1 BZXNEONCFZGWDS-UHFFFAOYSA-N 0.000 description 2
- 0 C[C@](C(O)=CC1=CC(*2CC*CC2)=CC*1)O Chemical compound C[C@](C(O)=CC1=CC(*2CC*CC2)=CC*1)O 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 235000011007 phosphoric acid Nutrition 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 239000012265 solid product Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- AKEJUJNQAAGONA-UHFFFAOYSA-N sulfur trioxide Chemical compound O=S(=O)=O AKEJUJNQAAGONA-UHFFFAOYSA-N 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- PYUFUUDEYQJLPV-UHFFFAOYSA-N 1-(1-benzofuran-5-yl)piperazine Chemical class C1CNCCN1C1=CC=C(OC=C2)C2=C1 PYUFUUDEYQJLPV-UHFFFAOYSA-N 0.000 description 1
- YHYLDEVWYOFIJK-UHFFFAOYSA-N 1h-indole-5-carbonitrile Chemical compound N#CC1=CC=C2NC=CC2=C1 YHYLDEVWYOFIJK-UHFFFAOYSA-N 0.000 description 1
- RVUAKHOQRXFLBH-UHFFFAOYSA-N 3-butyl-1h-indole-5-carbonitrile Chemical compound C1=C(C#N)C=C2C(CCCC)=CNC2=C1 RVUAKHOQRXFLBH-UHFFFAOYSA-N 0.000 description 1
- ACZGCWSMSTYWDQ-UHFFFAOYSA-N 3h-1-benzofuran-2-one Chemical compound C1=CC=C2OC(=O)CC2=C1 ACZGCWSMSTYWDQ-UHFFFAOYSA-N 0.000 description 1
- VYOHEOKELADMTR-UHFFFAOYSA-N 5-bromo-1-benzofuran-2-carboxamide Chemical compound BrC1=CC=C2OC(C(=O)N)=CC2=C1 VYOHEOKELADMTR-UHFFFAOYSA-N 0.000 description 1
- VXWVFZFZYXOBTA-UHFFFAOYSA-N 5-bromo-1h-indole Chemical class BrC1=CC=C2NC=CC2=C1 VXWVFZFZYXOBTA-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-M Methanesulfonate Chemical compound CS([O-])(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-M 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 101150003085 Pdcl gene Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000002723 alicyclic group Chemical group 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 238000005576 amination reaction Methods 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000000010 aprotic solvent Substances 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- LNOPIUAQISRISI-UHFFFAOYSA-N n'-hydroxy-2-propan-2-ylsulfonylethanimidamide Chemical compound CC(C)S(=O)(=O)CC(N)=NO LNOPIUAQISRISI-UHFFFAOYSA-N 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 238000006053 organic reaction Methods 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- BWHDROKFUHTORW-UHFFFAOYSA-N tritert-butylphosphane Chemical compound CC(C)(C)P(C(C)(C)C)C(C)(C)C BWHDROKFUHTORW-UHFFFAOYSA-N 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D307/85—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Indole Compounds (AREA)
- Furan Compounds (AREA)
Abstract
Description
その結果、これは低溶剤および低エネルギー消費を意味する。
Lは、Cl、Br、I、SO2F、SO2CF3、SO2C2F5を示す、
で表される化合物を、Pd錯体によって遷移金属触媒カップリングにより3−(4−ピペラジン−1−イルブチル)インドール−5−カルボニトリルと反応させ、
および/または形成された5−(4−[4−(5−シアノ−3−インドリル)ブチル]−1−ピペラジニル)ベンゾフラン−2−カルボキサミドを、酸処理によりその酸付加塩の1つに変換する。(方法の改良型a))
使用する基Lは、好ましくは臭素である。
使用する反応条件に依存して、反応時間は数分〜7日であり、反応温度は0〜150℃、好ましくは20〜120℃である。
還元的アミノ化により3−(4−オキソブチル)−1H−インドール−5−カルボニトリルと反応させ、
および/または5−(4−[4−(5−シアノ−3−インドリル)ブチル]−1−ピペラジニル)ベンゾフラン−2−カルボキサミドを、酸処理によりその酸付加塩の1つに変換する(方法の改良型b))。
J. Med. Chem. (2004), 47(19), 4684-4692, Heinrich, T.; Boettcher, H.; Gericke, R.; Bartoszyk, G. D.; Anzali, S.; Seyfried, C. A.; Greiner, H. E.; van Amsterdam, C.およびそれらに引用されている文献に記載されているように、(3−(4−オキソブチル)−1H−インドール−5−カルボニトリル)を使った還元的アミノ化による試薬3−(4−クロロブチル)インドール−5−カルボニトリルとのアルキル化段階の置換が可能である。
例1:
保護ガス下で、80mgのトリス(ジベンジリデンアセトン)ジパラジウムおよび65mgのトリス−tert−ブチルホスフィンを、70mlのジエチレングリコールジメチルエーテルに20℃で攪拌しながら導入する。1.5gの5−ブロモベンゾフラン−2−カルボキサミドおよび2.5gの3−(4−ピペラジン−1−イルブチル)インドール−5−カルボニトリルを、その後に導入する。次の2.3gのナトリウムtert−ブトキシドの添加の際、黄灰色の懸濁液を形成する。反応混合物を120℃で48時間加熱し、そして反応混合物を室温(約23℃)に冷却し、従来の実験方法を使って作業し、目標化合物を、任意に含水塩酸を含む溶解塩基の処理後、vilazodoneの塩基としてまたは一塩酸塩(=vilazodone/塩酸5−{4−[4−(5−シアノ−3−インドリル)ブチル]−1−ピペラジニル}ベンゾフラン−2−カルボキサミド)として単離する。
例2:
前駆体3−(4−オキソブチル)−1H−インドール−5−カルボニトリル
18gの3−(4−ヒドロキシブチル)−1H−インドール−5−カルボニトリルおよび34mlのトリエチルアミンを、300mlのジクロロメタン中に溶解させ、氷/メタノール浴中で約0℃に冷却する。39gの三酸化硫黄/ピリジン錯体および140mlのジメチルスルホキシドの溶液を、その後に2〜5℃で測定する。混合物を、2〜3℃でおよそ20分間さらに攪拌し、そして反応溶液を、22〜23℃(室温)で2時間にわたり加温する。反応混合物を、さらなる200mlのジクロロメタンの添加により希釈し、そして水、10%のクエン酸溶液および10%の塩化ナトリウム溶液で抽出した。有機相を真空下で油性残渣に濃縮し、そしてシリカゲル上にジクロロメタンおよびMTBエーテルの混合物を使ってクロマトグラフィー処理する。
比較H NMRおよびMSにより、同一性を確認する。
20℃で、1.7gの5−(1−ピペラジニル)ベンゾフラン−2−カルボキサミドおよび1.1gのシアノ水素化ホウ素ナトリウムを、200mlのメタノール中に攪拌しながら溶解する。2.4gの3−(4−オキソブチル)−1H−インドール−5−カルボニトリルおよび50mlのメタノールの溶液を、15分間にわたりこの温度で添加する。反応混合物を、20℃でおよそ18時間攪拌し、そして10℃に6時間冷却する。沈殿した固体の生成物を分離し、メタノールおよび水で洗浄し、真空下で乾燥させる。固体の残留物を、テトラヒドロフランに20℃で攪拌しながら溶解させ、ろ過する。含水1N HClを、ろ液に添加する。反応混合物を、さらに20℃で攪拌し、そして沈殿した固体の生成物をろ過する。ろ過残渣を、THFおよび水で洗浄し、および真空下で熱乾燥させる。
Claims (4)
- 5−(4−[4−(5−シアノ−3−インドリル)ブチル]−1−ピペラジニル)ベンゾフラン−2−カルボキサミドおよび/またはその生理学的に許容しうる塩の1つの製造方法であり、式I
Lは、Cl、Br、I、SO2F、SO2CF3、SO2C2F5を示す、
で表される化合物を、Pd錯体によって遷移金属触媒カップリングにより3−(4−ピペラジン−1−イルブチル)インドール−5−カルボニトリルと反応させること、
および/または形成された5−(4−[4−(5−シアノ−3−インドリル)ブチル]−1−ピペラジニル)ベンゾフラン−2−カルボキサミドを、酸処理によりその酸付加塩の1つに変換することを特徴とする、前記方法。 - 式Iで表される化合物のLがBrを示すことを特徴とする、請求項1に記載の方法。
- 使用される遷移金属触媒系が、トリス(ジベンジリデンアセトン)−ジパラジウムまたは類似Pd(0)錯体であることを特徴とする、請求項1または2に記載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005019670.5 | 2005-04-26 | ||
DE102005019670A DE102005019670A1 (de) | 2005-04-26 | 2005-04-26 | Verfahren zur Herstellung von (5-(4-[4-(5-Cyano-3-indolyl)-butyl)-1-piperazinyl)-benzofuran-2-carboxamid |
PCT/EP2006/003344 WO2006114202A1 (de) | 2005-04-26 | 2006-04-12 | Verfahren zur herstellung von 5-(4-[4-(5-cyano-3-indolyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamid |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012175557A Division JP5735465B2 (ja) | 2005-04-26 | 2012-08-08 | 5−(4−[4−(5−シアノ−3−インドリル)ブチル]−1−ピペラジニル)ベンゾフラン−2−カルボキサミドの製造方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2008539178A true JP2008539178A (ja) | 2008-11-13 |
JP5113039B2 JP5113039B2 (ja) | 2013-01-09 |
Family
ID=36603535
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008508108A Active JP5113039B2 (ja) | 2005-04-26 | 2006-04-12 | 5−(4−[4−(5−シアノ−3−インドリル)ブチル]−1−ピペラジニル)ベンゾフラン−2−カルボキサミドの製造方法 |
JP2012175557A Active JP5735465B2 (ja) | 2005-04-26 | 2012-08-08 | 5−(4−[4−(5−シアノ−3−インドリル)ブチル]−1−ピペラジニル)ベンゾフラン−2−カルボキサミドの製造方法 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012175557A Active JP5735465B2 (ja) | 2005-04-26 | 2012-08-08 | 5−(4−[4−(5−シアノ−3−インドリル)ブチル]−1−ピペラジニル)ベンゾフラン−2−カルボキサミドの製造方法 |
Country Status (21)
Country | Link |
---|---|
US (1) | US7799916B2 (ja) |
EP (1) | EP1874762B1 (ja) |
JP (2) | JP5113039B2 (ja) |
KR (1) | KR101310191B1 (ja) |
CN (1) | CN101163698B (ja) |
AT (1) | ATE420875T1 (ja) |
AU (1) | AU2006239569B2 (ja) |
BR (2) | BRPI0610336B8 (ja) |
CA (1) | CA2605758A1 (ja) |
CY (1) | CY1108904T1 (ja) |
DE (2) | DE102005019670A1 (ja) |
DK (1) | DK1874762T3 (ja) |
ES (1) | ES2320172T3 (ja) |
HK (1) | HK1116492A1 (ja) |
MX (1) | MX2007013258A (ja) |
PL (1) | PL1874762T3 (ja) |
PT (1) | PT1874762E (ja) |
RU (1) | RU2397981C2 (ja) |
SI (1) | SI1874762T1 (ja) |
WO (1) | WO2006114202A1 (ja) |
ZA (1) | ZA200710145B (ja) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102267932A (zh) * | 2011-06-15 | 2011-12-07 | 上海医药工业研究院 | 4-(5-氰基-1h-吲哚-3-基)丁基取代磺酸酯类化合物及其应用 |
CN102267985B (zh) * | 2011-06-15 | 2015-12-09 | 上海医药工业研究院 | 维拉佐酮或其盐酸盐的制备方法 |
CN102949364A (zh) * | 2011-08-30 | 2013-03-06 | 天津药物研究院 | 一种含有效成分盐酸维拉佐酮的缓释片 |
WO2013114338A1 (en) * | 2012-02-01 | 2013-08-08 | Ranbaxy Laboratories Limited | Process for the preparation of vilazodone or its pharmaceutically acceptable salts |
WO2013168126A1 (en) | 2012-05-11 | 2013-11-14 | Dr.Reddys Laboratories Limited | Crystalline forms of vilazodone hydrochloride and vilazodone free base |
WO2013175361A1 (en) * | 2012-05-24 | 2013-11-28 | Ranbaxy Laboratories Limited | Process for the preparation of vilazodone hydrochloride |
CN102796037B (zh) * | 2012-08-09 | 2013-11-06 | 成都苑东药业有限公司 | 一种3-(4-(4-取代哌嗪)-1-丁酰基)吲哚-5-甲腈及其用途 |
WO2014028473A1 (en) * | 2012-08-13 | 2014-02-20 | Assia Chemical Industries Ltd. | New salts of vilazodone and solid state forms thereof |
CN102875538A (zh) * | 2012-10-16 | 2013-01-16 | 北京诚创思达医药科技有限公司 | 维拉唑酮或其盐酸盐的制备方法 |
WO2014061004A2 (en) * | 2012-10-19 | 2014-04-24 | Ranbaxy Laboratories Limited | Process for the preparation of vilazodone or pharmaceutically acceptable salt thereof |
WO2014064715A2 (en) * | 2012-10-22 | 2014-05-01 | Cadila Healthcare Limited | Amorphous form of vilazodone hydrochloride and process for preparing thereof |
WO2014199313A1 (en) | 2013-06-12 | 2014-12-18 | Lupin Limited | Substantially pure vilazodone hydrochloride and a process thereof |
CN105017233A (zh) * | 2014-04-23 | 2015-11-04 | 天津药物研究院 | 一种盐酸维拉佐酮晶体、其制备方法、药物组合物和用途 |
CN103965148B (zh) * | 2014-05-15 | 2016-04-06 | 北京北陆药业股份有限公司 | 一种5-(哌嗪-1-基)苯并呋喃-2-羧酸乙酯的合成方法 |
CN107501159B (zh) * | 2017-08-14 | 2020-11-24 | 连云港恒运药业有限公司 | 维拉佐酮中间体3-(4-氯丁基)-5-氰基吲哚合成方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07149762A (ja) * | 1993-09-30 | 1995-06-13 | Merck Patent Gmbh | ピペリジン類およびピペラジン類 |
WO2004041815A1 (de) * | 2002-11-08 | 2004-05-21 | Merck Patent Gmbh | Indolderivate mit 5ht1a affinität |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19514567A1 (de) * | 1995-04-20 | 1996-10-24 | Merck Patent Gmbh | Benzofurane |
DE10217006A1 (de) * | 2002-04-16 | 2003-11-06 | Merck Patent Gmbh | Substituierte Indole |
-
2005
- 2005-04-26 DE DE102005019670A patent/DE102005019670A1/de not_active Withdrawn
-
2006
- 2006-04-12 BR BRPI0610336A patent/BRPI0610336B8/pt active IP Right Grant
- 2006-04-12 AU AU2006239569A patent/AU2006239569B2/en active Active
- 2006-04-12 DK DK06724257T patent/DK1874762T3/da active
- 2006-04-12 PL PL06724257T patent/PL1874762T3/pl unknown
- 2006-04-12 AT AT06724257T patent/ATE420875T1/de active
- 2006-04-12 EP EP06724257A patent/EP1874762B1/de active Active
- 2006-04-12 KR KR1020077027178A patent/KR101310191B1/ko not_active IP Right Cessation
- 2006-04-12 PT PT06724257T patent/PT1874762E/pt unknown
- 2006-04-12 CA CA002605758A patent/CA2605758A1/en not_active Abandoned
- 2006-04-12 MX MX2007013258A patent/MX2007013258A/es active IP Right Grant
- 2006-04-12 RU RU2007143504/04A patent/RU2397981C2/ru not_active IP Right Cessation
- 2006-04-12 JP JP2008508108A patent/JP5113039B2/ja active Active
- 2006-04-12 US US11/912,584 patent/US7799916B2/en active Active
- 2006-04-12 BR BR122020011626A patent/BR122020011626B8/pt active IP Right Grant
- 2006-04-12 SI SI200630203T patent/SI1874762T1/sl unknown
- 2006-04-12 DE DE502006002659T patent/DE502006002659D1/de active Active
- 2006-04-12 ES ES06724257T patent/ES2320172T3/es active Active
- 2006-04-12 CN CN2006800138161A patent/CN101163698B/zh active Active
- 2006-04-12 WO PCT/EP2006/003344 patent/WO2006114202A1/de active Application Filing
-
2007
- 2007-11-26 ZA ZA200710145A patent/ZA200710145B/xx unknown
-
2008
- 2008-06-24 HK HK08106976.7A patent/HK1116492A1/xx not_active IP Right Cessation
-
2009
- 2009-03-23 CY CY20091100335T patent/CY1108904T1/el unknown
-
2012
- 2012-08-08 JP JP2012175557A patent/JP5735465B2/ja active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07149762A (ja) * | 1993-09-30 | 1995-06-13 | Merck Patent Gmbh | ピペリジン類およびピペラジン類 |
WO2004041815A1 (de) * | 2002-11-08 | 2004-05-21 | Merck Patent Gmbh | Indolderivate mit 5ht1a affinität |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5735465B2 (ja) | 5−(4−[4−(5−シアノ−3−インドリル)ブチル]−1−ピペラジニル)ベンゾフラン−2−カルボキサミドの製造方法 | |
JP5524041B2 (ja) | エルロチニブおよびその薬学的に許容可能な塩の製造方法 | |
JP5426828B2 (ja) | アリピプラゾールの塩 | |
JP5827407B2 (ja) | 4−[5−(ピリジン−4−イル)−1h−1,2,4−トリアゾール−3−イル]ピリジン−2−カルボニトリルの製造方法および中間体 | |
JP2013531054A (ja) | アミノベンゾイルベンゾフラン誘導体を調製する方法 | |
JP2005350474A (ja) | シロスタゾールの製造方法 | |
CN109748902B (zh) | 一种盐酸安罗替尼的制备方法 | |
US20150073148A1 (en) | Process for the preparation of crystalline vilazodone hydrochloride | |
JP6248202B2 (ja) | シロドシン及びその中間体の製造方法 | |
KR100654265B1 (ko) | 4-(헤테로아릴-메틸)-할로겐-1(2h)-프탈라지논의 제조 방법 | |
CN111087324B (zh) | 一种多拉米胺的合成方法 | |
TWI845992B (zh) | 一種b肝病毒核衣殼抑制劑的製備方法 | |
CN105481831A (zh) | 一种制备达比加群酯中间体的新方法 | |
Santiago Alvarez et al. | Microwave-assisted Palladium catalysed CH acylation with aldehydes. Synthesis and diversification of 3-acylthiophenes | |
JP3983979B2 (ja) | 3−(ヒドロキシメチル)クロメン−4−オン類およびその製造方法 | |
KR100453379B1 (ko) | 피페리딘 유도체의 제조방법 | |
JP2001523681A (ja) | 塩酸テラゾシン二水和物の製造 | |
JP2004244417A (ja) | 5−ホルミル−2−メトキシ安息香酸及びそのエステルの製造方法、及びその製造中間体 | |
JP2001278864A (ja) | 4−メトキシキノリン類の製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20080806 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20090410 |
|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20090410 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120508 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120808 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20120911 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20121011 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20151019 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5113039 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |